REDUCTION IN HEPATIC IRON STORES WITH THE ORAL IRON CHELATOR-L1 IN PATIENTS (PTS) WITH TRANSFUSION-DEPENDENT THALASSEMIA (HBT) AND SICKLE-CELL DISEASE (SCD) - 1ST 3 YEARS OF THE CANADIAN TRIAL

Authors
BERKOVITCH M OLIVIERI NF BRITTENHAM GM KOREN G
Citation
M. Berkovitch et al., REDUCTION IN HEPATIC IRON STORES WITH THE ORAL IRON CHELATOR-L1 IN PATIENTS (PTS) WITH TRANSFUSION-DEPENDENT THALASSEMIA (HBT) AND SICKLE-CELL DISEASE (SCD) - 1ST 3 YEARS OF THE CANADIAN TRIAL, Pediatric research, 35(4), 1994, pp. 10000158-10000158
Citations number
NO
Categorie Soggetti
Pediatrics
Journal title
Pediatric research → ACNP
ISSN journal
00313998
Volume
35
Issue
4
Year of publication
1994
Part
2
Pages
10000158 - 10000158
Database
ISI
SICI code
0031-3998(1994)35:4<10000158:RIHISW>2.0.ZU;2-L